Correlation between germ tube production, phospholipase activity and serotype distribution in Candida albicans

Revista Iberoamericana de Micologia

Volumn 16, Issue 4, 1999, Pages 208-210

  Vidotto, Valerio ^a,d   Koga Ito, Cristiane Yumi ^a   Milano, Rosangela ^b   Fianchino, Barbara ^b   Pontón, José ^c  

^a Dipartimento Discipline Medico Chirurgiche   (Italy)

^b Ospedale Amedeo di Savoia   (Spain)

^c UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^d Dipto Discipline Medico Chirurgiche   (Italy)

Author keywords

Candida albicans; Germ tube; Phospholipase; Serology; Virulence

Indexed keywords

PHOSPHOLIPASE;

ARTICLE; CANDIDA ALBICANS; ENZYME ACTIVITY; ENZYME SYNTHESIS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOUTH CAVITY; NONHUMAN; SEROTYPE; STRAIN DIFFERENCE;

EID: 0033393908     PISSN: 11301406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Ajello L, Hay RJ Microbiology and microbial infections. Ninth edition Medical Mycology., Vol 4, Arnold, London, 1998.
2. Mendoza M, Russian E, Villanueva E, de Torres ED, de Albornoz MB. Sensibilidad de los serotipos A y B de Candida albicans y de otras levaduras del genero Candida trente a diferentes azoles. Rev Iberoam Micol 1994; 11: 74-76
3. Barturen B, Quindós G, San Millán R, et al Distribución de los serotipos de Candida albicans en aislarnintos clínicos de personas inmunocompetentes e inmunodeprimidas Rev Iberoam Micol 1996; 13:10-13.
4. Ghannoum MA, Abu-Elteen K. Correlative relationship between proteinase production, adherence and pathogenicity of various strains of Candida albicans. J Met Vet Mycol. 1986; 24: 407-441.
5. Odds FC. Pathogenesis of candidosis. In: Odds FC (Ed). Candida and candidosis. 2nd ed London, Ballière Tindall, 1998: 252-278.
6. Goyal S, Khuler GK. Phospholipids and subcellular distribution in yeast and mycelial form of Candida albicans. J Med Vet Mycol 1992; 30: 355-362
7. Polak A Virulence of Candida albicans mutants Mycoses 1992; 35: 9-16.
8. Hanel H, Kirsch R, Schmidts H, Kuttmann H. New systematically active antimycotics from the beta-blocker category. Mycoses 1995; 38: 251-264.
9. Cardaropoli S, Di Fraia D, Menegatti E, Aoki S, Vidotto V. Correlation between chlamydosporulation, germ tube, phospholipase and proteinase production in Candida albicans. J Mycot Med 1997; 7:169-170.
10. Gow NA. Germ tube growth of Candida albicans. Curr Top Med Mycol 1997; 8: 43-55.
11. Vidotto V, Polonelli L, Conti S, Ponton J, Vieta I. Factors influencing the expression in vitro of Candida albicans stress mannoproteins reactive with salivary secretory IgA. Mycopathology 1998; 141 1-6
12. Ghannoum MA Extracellular phospholipases as universal virulence factor in pathogenic fungi. Nippon Ishinkin Gakkai Zasshi 1998; 39:55-59.
13. Hube B, Ruchel R, Monod M, Sanglard D, Odds F. Functional aspects of secreted Candida proteinases. Adv Exp Med Biol 1998;436:339-344.
14. Price MF, Wilkinson ID, Gentry LO. Plate method for detection of phospholipase activity in Candida albicans. Sabouraudia 1982; 20: 7-14.
15. Bruatto M, Gremmi M, Vidotto V. A new minimal synthetic medium for germ-tube production in Candida albicans Mycopathologia 1991, 116:159-163.
16. Barturen B, Bikandi J, San Millán R, et al Variability in expression of antigens responsible for serotype specificity in Candida albicans. Microbiology 1995; 141:1535-1543.
17. Drouhet E, Mercier-Soncy L, Montplaisir S. Sensibilité et résistance des levures pathogenes aux 5-fluoropyrimidines I: Relation entre le phénotypes de résistance a 5-fluorocytosine le serotype de Candida albicans et l'écologie de différen-tes especes de Candida d'origine humaine. Ann Microbiol (Paris) 1975; 126B: 25-39
18. Stiller RL,Bennett JE, Scholer HJ, Wall M, Polack A, Stevens DA Susceptibility to 5-fluorocytosine and prevalence of serotype in 402 C. albicans isolates from the United States. Antimicrob Agents Chemother 1982; 22:482-487.
19. Whelan WL, Kirsch DR, Kwong-Chung KJ, Walsh SM, Smith PD. Candida albicans in patients with the acquired immunodeficiency syndrome. Absence of a novel or hypervirulent strain. Infect Immun 1990; 58:1552-1557.
20. Brawner DL, Cutler JE. Oral Candida albicans isolates from non-hospitalized normal carriers, immunocompetent hospitalized patients and immunocompromised patients with or without acquired immunodeficency syndrome. J Clin Microbiol 1989, 27: 1335-1341.
21. Cutler J Putative virulence factors of Candida albicans. Ann Rev Microbiol 1991, 45:187-218.
22. Gale CA, Bendel CM, McClellan M, et al. Linkage of adhesion, filamentous growth, and virulence in Candida albicans to a single gene, INT1. Science 1998; 279: 1355-1358
23. Pugh D, Cawson RA The cytochemical localization of phospholipase in Candida albicans infecting the chick chorio-allantoic membrane. Sabouraudia 1977; 15: 29-35.
24. Samaranayake LP, Reaside JM, MacFarlane TW. Factors affecting the phospholipase activity of Candida species in vitro. Sabouraudia 1984, 22:201-207.